Clinical Images: Biopsy‐proven hydroxychloroquine‐induced cardiomyopathy in an adolescent with systemic lupus erythematosus
Arthritis &Rheumatology, EarlyView.
Wiley
Wiley
Wiley
Performance of an Idiopathic Pulmonary Fibrosis–Derived Multibiomarker Panel for Rheumatoid Arthritis–Associated Interstitial Lung Disease
Objective To assess whether a panel of peripheral blood biomarkers associated with idiopathic pulmonary fibrosis (IPF) is also associated with
Wiley
Distinct HLA Associations for Antibody Multireactivity With Citrulline‐Containing Type II Collagen Epitopes Versus More Limited Antibody Reactivity With Citrulline‐Containing IgG Epitopes in Rheumatoid Arthritis
Objective Anticitrullinated protein antibodies (ACPAs) in rheumatoid arthritis (RA) can be promiscuous, with cross-reactive binding to many antigens containing short
Wiley
Genome‐Wide DNA Methylation Study Reveals Specific Signatures in the Affected Arterial Tissue of Patients With Giant Cell Arteritis
Objective Giant cell arteritis (GCA) is a large-vessel vasculitis, potentially causing complications such as blindness and strokes. This study aims
Wiley
Less Is More: Hematologic Safety and Sustained Efficacy of a Modified Low‐Dose Etoposide Regimen in Macrophage Activation Syndrome
Arthritis &Rheumatology, EarlyView.
Wiley
Is serum uric acid a mere bystander or an active player in osteoarthritis pathogenesis? Comment on the article by Xu et al
Arthritis &Rheumatology, EarlyView.
Wiley
Thigh intramuscular fat infiltration as a risk factor for knee and hip osteoarthritis: comment on the article by Weng et al
Arthritis &Rheumatology, Volume 77, Issue 12, Page 1809-1810, December 2025.
Wiley
Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al
Arthritis &Rheumatology, Volume 77, Issue 12, Page 1800-1800, December 2025.
Wiley
Reactive Oxygen Species–Induced Modifications of Fibrin Clots as a Link Between Immune Responses and Atherothrombosis in Systemic Lupus Erythematosus
Objective Cardiovascular events are major determinants of morbidity and mortality in systemic lupus erythematosus (SLE), particularly in patients with renal
Wiley
Measuring the Impact: MRI Response of Sacroiliac Joints to TNF Inhibitors in Youth with Axial Disease
Objective To evaluate the timeline for resolution of sacroiliac joint (SIJ) inflammation, changes in structural lesions, and their correlation with
Wiley
Transition From Psoriasis to Psoriatic Arthritis is Characterized by Distinct Alterations in Peripheral Blood Tc17, Th17, and CD4+ Effector Memory Cells
Objective Cellular mechanisms driving transition from psoriasis to psoriatic arthritis have remained largely elusive. Thus, we investigated changes within the
Wiley
Efficacy of Telitacicept in Childhood‐Onset Systemic Lupus Erythematosus: A Prospective Multicenter Cohort Study With Inverse Probability of Treatment Weighting –Adjusted Comparison to a Historical Control Group Treated With Belimumab
Objective The therapeutic effects of telitacicept combined with standard of care (SoC) in childhood-onset systemic lupus erythematosus (cSLE) remain unclear.
Wiley
Clinical Images: Successfully treated mandibular osteomyelitis by tumor necrosis factor inhibitor in SAPHO syndrome
Arthritis &Rheumatology, EarlyView.
Wiley
Diagnostic Implications and Correlates of Plasma Adenosine Deaminase 2 Activity and ADA2 Variants
Objective Deficiency of adenosine deaminase 2 (DADA2) is a monogenic autoinflammatory disease manifested as polyarteritis nodosa, stroke, and bone marrow
Wiley
Per‐ and polyfluoroalkyl substances and hand osteoarthritis: data from the Osteoarthritis Initiative
Objective To explore whether biological levels of specific per- and polyfluoroalkyl substances (PFAS) and a mixture of PFAS – reflecting
Wiley
Decision tree analysis as a preliminary evidence‐based tool for identifying the syndrome of undifferentiated recurrent fever in children compared with hereditary recurrent fevers and periodic fever, aphthosis, pharyngitis and adenitis syndrome
Objective To develop evidence-based criteria to classify SURF patients. Methods 112 SURF patients followed in a single tertiary referral center
Wiley
Weighing dose‐related benefits and risks of hydroxychloroquine treatment in systemic lupus erythematosus patients
Abstracts Objective To weigh higher-dose HCQ (>=400 mg/d) and lower-dose HCQ (<400 mg/d) for effectiveness and safety among patients with
Wiley
Prognostic Value of Lupus Anticoagulant and Anti–β2 Glycoprotein I Antibody in Adverse Pregnancy Outcomes
Objective International criteria for antiphospholipid syndrome (APS) include lupus anticoagulant (LA), anticardiolipin (aCL) IgG and IgM, and anti–β2-glycoprotein I (β2GPI)
Wiley
Mesenchymal Stromal Cell Therapy Alleviates Lupus Nephritis Through Inhibiting Caspase‐4/5/11–Mediated Noncanonical Pyroptosis in Macrophages
Objective Caspase-4/5/11–mediated noncanonical pyroptosis emerges as a contributing factor in immune responses under pathologic conditions. However, its precise role in
Wiley
Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The
Wiley
Risk factors for relapse in ANCA‐associated vasculitis among patients with relapse after induction of remission with rituximab
Objective To determine risk factors for relapse of ANCA-associated vasculitis (AAV) after re-induction of remission with rituximab and discontinuation of
Wiley
A cooperative release of mitochondrial DNA from platelets and neutrophils drives an interferon signature in systemic sclerosis
Objective Mitochondria are organelles with a hypomethylated circular genome. Mitochondrial DNA (mtDNA) in the systemic circulation has been implicated in
Wiley
Interleukin‐18 levels are associated with disease course in patients with Still’s disease treated with IL‐1 inhibitors
Objective To evaluate the prognostic utility of circulating Interleukin-18 (IL-18) levels in predicting disease activity, macrophage activation syndrome (MAS), and
Wiley
Molecular stratification of antiphospholipid syndrome through integrative analysis of the whole‐blood RNA transcriptome
Objective Antiphospholipid syndrome (APS) is a thrombo-inflammatory disorder characterized by clinical and mechanistic heterogeneity that complicates early diagnosis and hinders
Wiley
Klippel‐Feil Syndrome in a Patient Referred for Axial Spondyloarthritis
Arthritis &Rheumatology, Accepted Article.